Rational design of HER2-targeted combination therapies to reverse drug resistance in fibroblast-protected HER2+ breast cancer cells
Preprint in bioRxiv (May 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Preprint in bioRxiv (May 2024)
Article in Biomedicines (March 2023)
Article in npj Precision Oncology (July 2022)